Cancer: The Road to Amiens-Reference-Cited by-同舟云学术

Cancer: The Road to Amiens

Published:2009-01-20 Issue:3 Volume:27 Page:328-333
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Stewart David J.¹,Kurzrock Razelle²

Affiliation:

1. Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

2. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas M. D. Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.18.9621

Reference33 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

2. FDA Drug Approval Summary: Bevacizumab Plus FOLFOX4 as Second-Line Treatment of Colorectal Cancer

3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

4. FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

5. Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It is time to rethink randomized clinical trial approaches;The Oncologist;2024-07-10

2. New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices;Current Oncology;2024-04-28

3. A data management system for precision medicine;2024-02-11

4. For insights into the real world, consider real-world data;Science Translational Medicine;2022-11-30

5. Treating non-small cell lung cancer with selumetinib: an up-to-date drug evaluation;Expert Opinion on Pharmacotherapy;2020-09-03